Finepoint Capital LP Diversified Active

Location: Boston, MA

CIK: 0001608126 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 14, 2024

Total Value: $390M (96.6% shares, 3.4% debt)

Holdings (26)

LBRDK LIBERTY BROADBAND CORP 27.7%

Value $108M Shares 1,886,260 Est. Cost $63.56 Unrealized -2.6%

— SPRINGWORKS THERAPEUTICS INC 7.5%

Value $29.16M Shares 592,528 Est. Cost $28.54 Unrealized —

ASND ASCENDIS PHARMA A/S 6.8%

Value $26.56M Shares 175,672 Est. Cost $100.18 Unrealized —

ARVN ARVINAS INC 5.7%

Value $22.25M Shares 539,100 Est. Cost $42.13 Unrealized +3.7%

RVMD REVOLUTION MEDICINES INC 5.6%

Value $21.82M Shares 677,100 Est. Cost $28.08 Unrealized +5.6%

SRPT SAREPTA THERAPEUTICS INC 5.3%

Value $20.51M Shares 158,457 Est. Cost $116.29 Unrealized +5.3%

ARGX ARGENX SE 5.0%

Value $19.69M Shares 50,000 Est. Cost $393.72 Unrealized —

MLTX MOONLAKE IMMUNOTHERAPEUTICS 4.6%

Value $18.13M Shares 360,916 Est. Cost $43.35 Unrealized +25.1%

CYTK CYTOKINETICS INC 4.3%

Value $16.69M Shares 238,046 Est. Cost $39.39 Unrealized +96.4%

GLPG GALAPAGOS NV 4.2%

Value $16.22M Shares 503,759 Est. Cost $46.71 Unrealized —

ACAD ACADIA PHARMACEUTICALS INC 4.0%

Value $15.54M Shares 840,453 Est. Cost $19.83 Unrealized +24.9%

EYPT EYEPOINT PHARMACEUTICALS INC 3.5%

Value $13.57M Shares 656,600 Est. Cost $24.76 Unrealized 0.0%

— DISH NETWORK CORPORATION 3.4%

Value $13.45M Shares 18,300,000 Est. Cost $0.73 Unrealized —

SLDB SOLID BIOSCIENCES INC 3.3%

Value $12.8M Shares 961,251 Est. Cost $5.95 Unrealized +57.4%

TVTX TRAVERE THERAPEUTICS INC 3.3%

Value $12.72M Shares 1,649,221 Est. Cost $16.38 Unrealized -48.5%

RLAY RELAY THERAPEUTICS INC 3.2%

Value $12.37M Shares 1,490,170 Est. Cost $13.80 Unrealized -29.3%

PRTA PROTHENA CORP PLC 2.6%

Value $9.967M Shares 402,400 Est. Cost $33.43 Unrealized -11.0%

— CHURCHILL CAPITAL CORP VII 0.0%

Value $175K Shares 548,000 Est. Cost $0.92 Unrealized —

MNYWW MONEYHERO LIMITED 0.0%

Value $108K Shares 895,000 Est. Cost $0.12 Unrealized —

— CALIDI BIOTHERAPEUTICS INC 0.0%

Value $70,625 Shares 125,000 Est. Cost $3.33 Unrealized —

CNDAW CONCORD ACQUISITION CORP II 0.0%

Value $45,447 Shares 408,333 Est. Cost $0.95 Unrealized —

CDAWF COMPASS DIGITAL ACQUISITION CORP 0.0%

Value $42,311 Shares 459,906 Est. Cost $0.76 Unrealized —

CLDWW CALIDI BIOTHERAPEUTICS INC 0.0%

Value $34,070 Shares 655,200 Est. Cost $0.50 Unrealized —

IVCPW SWIFTMERGE ACQUISITION CORP 0.0%

Value $27,391 Shares 490,000 Est. Cost $0.21 Unrealized —

LSBWF YS BIOPHARMA CO LTD 0.0%

Value $24,990 Shares 489,999 Est. Cost $0.16 Unrealized —

— MARBLEGATE ACQUISITION CORP 0.0%

Value $8,232 Shares 735,000 Est. Cost $0.50 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
LBRDK	LIBERTY BROADBAND CORP	1,886,260	$108M	27.7%	$63.56	-2.6%	COM SER C	530307305
—	SPRINGWORKS THERAPEUTICS INC	592,528	$29.16M	7.5%	$28.54	—	COM	85205L107
ASND	ASCENDIS PHARMA A/S	175,672	$26.56M	6.8%	$100.18	—	SPONSORED ADR	04351P101
ARVN	ARVINAS INC	539,100	$22.25M	5.7%	$42.13	+3.7%	COM	04335A105
RVMD	REVOLUTION MEDICINES INC	677,100	$21.82M	5.6%	$28.08	+5.6%	COM	76155X100
SRPT	SAREPTA THERAPEUTICS INC	158,457	$20.51M	5.3%	$116.29	+5.3%	COM	803607100
ARGX	ARGENX SE	50,000	$19.69M	5.0%	$393.72	—	SPONSORED ADR	04016X101
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	360,916	$18.13M	4.6%	$43.35	+25.1%	CLASS A ORD	61559X104
CYTK	CYTOKINETICS INC	238,046	$16.69M	4.3%	$39.39	+96.4%	COM NEW	23282W605
GLPG	GALAPAGOS NV	503,759	$16.22M	4.2%	$46.71	—	SPON ADR	36315X101
ACAD	ACADIA PHARMACEUTICALS INC	840,453	$15.54M	4.0%	$19.83	+24.9%	COM	004225108
EYPT	EYEPOINT PHARMACEUTICALS INC	656,600	$13.57M	3.5%	$24.76	0.0%	COM NEW	30233G209
—	DISH NETWORK CORPORATION	18,300,000	$13.45M	3.4%	$0.73	—	NOTE 12/1	25470MAF6
SLDB	SOLID BIOSCIENCES INC	961,251	$12.8M	3.3%	$5.95	+57.4%	COM NEW	83422E204
TVTX	TRAVERE THERAPEUTICS INC	1,649,221	$12.72M	3.3%	$16.38	-48.5%	COM	89422G107
RLAY	RELAY THERAPEUTICS INC	1,490,170	$12.37M	3.2%	$13.80	-29.3%	COM	75943R102
PRTA	PROTHENA CORP PLC	402,400	$9.967M	2.6%	$33.43	-11.0%	SHS	G72800108
—	CHURCHILL CAPITAL CORP VII	548,000	$175K	0.0%	$0.92	—	*W EXP 02/29/202	17144M110
MNYWW	MONEYHERO LIMITED	895,000	$108K	0.0%	$0.12	—	*W EXP 09/13/202	G6202B119
—	CALIDI BIOTHERAPEUTICS INC	125,000	$70,625	0.0%	$3.33	—	COM NEW	320703101
CNDAW	CONCORD ACQUISITION CORP II	408,333	$45,447	0.0%	$0.95	—	*W EXP 99/99/999	20607U116
CDAWF	COMPASS DIGITAL ACQUISITION CORP	459,906	$42,311	0.0%	$0.76	—	*W EXP 09/29/202	G2476C123
CLDWW	CALIDI BIOTHERAPEUTICS INC	655,200	$34,070	0.0%	$0.50	—	*W EXP 03/14/202	320703119
IVCPW	SWIFTMERGE ACQUISITION CORP	490,000	$27,391	0.0%	$0.21	—	*W EXP 12/13/202	G63836111
LSBWF	YS BIOPHARMA CO LTD	489,999	$24,990	0.0%	$0.16	—	*W EXP 03/15/202	G9845F117
—	MARBLEGATE ACQUISITION CORP	735,000	$8,232	0.0%	$0.50	—	*W EXP 08/31/202	56608A113